Tag

Soligenix

Marburg virus

Soligenix Granted Orphan Drug Designation for Vaccine to Treat MARV Infection
coronavirus vaccine

Soligenix Announces $1.5M NIH Small Business Innovation Research Award
Handshake

Soligenix Appoints New Chief Financial Officer
healthcare vaccines

Soligenix Receives Additional NIAID Funding to Advance Development of Heat Stable Ricin Vaccine
DNA biotech

Soligenix Enters into a $10 Million Equity Purchase Agreement
lab

Soligenix Receives $617,000 in Non-Dilutive Financing from NJ’s Technology Business Tax Certificate Transfer Program
Soligenix logo

Soligenix Awarded NIAID Contract Valued up to $24.7 Million for the Development of Heat Stable RiVax™ Vaccine